Search Results - "Cesari, Frank"
-
1
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
Published in The European respiratory journal (01-03-2019)“…PBI-4050 is a novel orally active small-molecule compound with demonstrated anti-fibrotic activity in several models of fibrosis, including lung fibrosis. We…”
Get full text
Journal Article -
2
Fourteen-Day Evolution of COVID-19 Symptoms during the Third Wave in Nonvaccinated Subjects and Effects of Hesperidin Therapy: A Randomized, Double-Blinded, Placebo-Controlled Study
Published in Evidence-based complementary and alternative medicine (2022)“…COVID-19 symptoms can cause substantial disability, yet no therapy can currently reduce their frequency or duration. We conducted a double-blind…”
Get full text
Journal Article -
3
FP445PBI-4050 PROTECTS AGAINST RENAL AND PANCREATIC FIBROSIS IN TYPE II DIABETES
Published in Nephrology, dialysis, transplantation (01-05-2015)Get full text
Journal Article -
4
SP102ORAL TREATMENT WITH PBI-4050 REDUCES KIDNEY FIBROSIS
Published in Nephrology, dialysis, transplantation (01-05-2015)Get full text
Journal Article